Jasper Therapeutics, Inc., a clinical stage biotechnology company, focuses on the design and development of therapies to treat immune-mediated diseases. It is advancing a pipeline of medicines, including KP-104, a dual-complement inhibitor that has demonstrated positive outcomes in paroxysmal...
13 insider purchases on record · latest filing 2025-09-24.
Insiders have also filed 12 sale transactions at JSPR.